Atlas Trials

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Clinical trial NCT05564286 · COMPLETED

Trial details

NCT number
NCT05564286
Sponsor
Shantou University Medical College
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cervical CancerNasopharyngeal CancerChemotherapy-induced Nausea and VomitingRadiation-Induced Nausea and VomitingAntiemetic
Start date
2021-07-01
Primary completion
2023-07-31
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.